Canada Diabetes Care Devices Investment Opportunities

Analysis and Forecasts to 2012

Product Code GMD07485
Publication Date September 2008
Publisher Global Markets Direct
Product Type Report
Pages 157
ISBN Number not applicable
Change currency
PDF £1,895.00 €2,282 $2,996 BUY >
Order by fax
Ask a question about this product > Receive product alerts > Call now +44 20 7060 7474

Canada Diabetes Care Devices Investment Opportunities

Analysis and Forecasts to 2012

This report is an essential source for in-depth information and data relating to the Canada diabetes care devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the diabetes care devices in Canada

Scope

  • The report provides diabetes care devices information broken down into detailed categories and segments in Canada.
  • Total revenues, products sold, end users, and average pricing.
  • Market shares of all the key competitors.
  • Key pipeline products that are set to shape the market, broken down by sector.
  • Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
  • Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
  • Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
  • Key mergers and acquisitions, partnerships, private equity investments and IPOs.
  • Customer, hospitals and physicians data.

Reasons to buy

  • Gain a strong understanding of the diabetes care devices market in Canada.
  • Evaluate and compare the attractiveness of the market in the country.
  • Identify growth segments and opportunities in each industry sector within the country.
  • Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
  • Analyze the competitiveness of the market in the country and identify hotspots.
  • Develop strategies based on the latest product, brand, expansion and research and development news in the country.
  • Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
  • Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

Contents

  • 1 List of Tables
    • 1.2 List of Figures
  • 2 Introduction
    • 2.1 What Is This Report About?
    • 2.2 Definitions
      • 2.2.1 Diabetes Care Devices
        • 2.2.1.1 Glucose Monitoring
        • 2.2.1.2 Insulin Delivery
  • 3 Healthcare Sector Review
    • 3.1 Healthcare Expenditure
    • 3.2 Healthcare Infrastructure
    • 3.3 Healthcare Policy
  • 4 Diabetes Care Devices in Canada
    • 4.1 Diabetes Care Devices Overall Revenues (2000-2012)
    • 4.2 Diabetes Care Devices Overall Volume (2000-2012)
    • 4.3 Diabetes Care Devices Overall Company Share (2006-2007)
  • 5 Glucose Monitoring in Canada
    • 5.1 Glucose Monitoring Overall Revenues (2000-2012)
      • 5.1.1 Blood Glucose Test Strips Revenues (2000-2012)
      • 5.1.2 Blood Glucose Meters Revenues (2000-2012)
    • 5.2 Glucose Monitoring Overall Volume (2000-2012)
      • 5.2.1 Blood Glucose Test Strips Volume (2000-2012)
      • 5.2.2 Blood Glucose Meters Volume (2000-2012)
    • 5.3 Glucose Monitoring Average Price (2000-2012)
      • 5.3.1 Blood Glucose Meters Average Price (2000-2012)
      • 5.3.2 Blood Glucose Test Strips Average Price (2000-2012)
    • 5.4 Glucose Monitoring Distribution Share (2006-2007)
    • 5.5 Glucose Monitoring Company Share (2006-2007)
  • 6 Insulin Delivery in Canada
    • 6.1 Insulin Delivery Overall Revenues (2000-2012)
      • 6.1.1 Insulin Syringes Revenues (2000-2012)
      • 6.1.2 Insulin Pumps Revenues (2000-2012)
      • 6.1.3 Insulin Pens Revenues (2000-2012)
      • 6.1.4 Insulin Jet Injectors Revenues (2000-2012)
    • 6.2 Insulin Delivery Overall Volume (2000-2012)
      • 6.2.1 Insulin Syringes Volume (2000-2012)
      • 6.2.2 Insulin Pens Volume (2000-2012)
      • 6.2.3 Insulin Pumps Volume (2000-2012)
      • 6.2.4 Insulin Jet Injectors Volume (2000-2012)
    • 6.3 Insulin Delivery Average Price (2000-2012)
      • 6.3.1 Insulin Jet Injectors Average Price (2000-2012)
      • 6.3.2 Insulin Pens Average Price (2000-2012)
      • 6.3.3 Insulin Pumps Average Price (2000-2012)
      • 6.3.4 Insulin Syringes Average Price (2000-2012)
    • 6.4 Insulin Delivery Distribution Share (2006-2007)
    • 6.5 Insulin Delivery Company Share (2006-2007)
  • 7 F. Hoffmann-La Roche Ltd. Company Profile
    • 7.1 Company Overview
    • 7.2 Business Overview
      • 7.2.1 Diagnostics
      • 7.2.2 Pharmaceuticals
      • 7.2.3 History
    • 7.3 Value Chain Analysis
      • 7.3.1 Manufacturing
      • 7.3.2 Product Development
      • 7.3.3 Sales and Marketing
    • 7.4 SWOT Analysis
      • 7.4.1 F. Hoffmann-La Roche Ltd. Strengths
      • 7.4.2 F. Hoffmann-La Roche Ltd. Weaknesses
      • 7.4.3 F. Hoffmann-La Roche Ltd. Opportunities
      • 7.4.4 F. Hoffmann-La Roche Ltd. Threats
    • 7.5 Financial and Operational Review
      • 7.5.1 Financial Statements
      • 7.5.2 Financial Ratios
    • 7.6 Locations And Subsidiaries
  • 8 LifeScan, Inc. Company Profile
    • 8.1 Company Overview
    • 8.2 Business Overview
      • 8.2.1 Major Products and Services
      • 8.2.2 History
    • 8.3 Locations And Subsidiaries
    • 8.4 LifeScan, Inc. Pipeline Products
      • 8.4.1 Blood Glucose Test
        • 8.4.1.1 Product Overview
        • 8.4.1.2 Product Description
        • 8.4.1.3 Product Status
      • 8.4.2 OneTouch glucose meter
        • 8.4.2.1 Product Overview
        • 8.4.2.2 Product Description
        • 8.4.2.3 Product Status
        • 8.4.2.4 Product Milestone
  • 9 Abbott Laboratories Company Profile
    • 9.1 Company Overview
    • 9.2 Business Overview
      • 9.2.1 Diagnostics
      • 9.2.2 Nutritionals
      • 9.2.3 Pharmaceuticals
      • 9.2.4 Vascular
      • 9.2.5 Major Products and Services
      • 9.2.6 History
    • 9.3 Value Chain Analysis
      • 9.3.1 Manufacturing
      • 9.3.2 Product Development
      • 9.3.3 Sales and Marketing
    • 9.4 SWOT Analysis
      • 9.4.1 Abbott Laboratories Strengths
      • 9.4.2 Abbott Laboratories Weaknesses
      • 9.4.3 Abbott Laboratories Opportunities
      • 9.4.4 Abbott Laboratories Threats
    • 9.5 Financial and Operational Review
      • 9.5.1 Financial Statements
      • 9.5.2 Financial Ratios
    • 9.6 Locations And Subsidiaries
    • 9.7 Abbott Laboratories Pipeline Products
      • 9.7.1 Fully Biosorbable Stent
        • 9.7.1.1 Product Overview
        • 9.7.1.2 Product Description
        • 9.7.1.3 Product Status
        • 9.7.1.4 Product Milestone
      • 9.7.2 FreeStyle Navigator Continuous Glucose Monitoring System
        • 9.7.2.1 Product Overview
        • 9.7.2.2 Product Description
        • 9.7.2.3 Product Status
        • 9.7.2.4 Product Milestone
      • 9.7.3 Wallis System
        • 9.7.3.1 Product Overview
        • 9.7.3.2 Product Description
        • 9.7.3.3 Product Status
        • 9.7.3.4 Product Milestone
  • 10 Novo Nordisk A/S Company Profile
    • 10.1 Company Overview
    • 10.2 Business Overview
      • 10.2.1 Major Products and Services
      • 10.2.2 History
    • 10.3 Locations and Subsidiaries
    • 10.4 Novo Nordisk A/S Pipeline Products
      • 10.4.1 Future inhalation systems
        • 10.4.1.1 Product Overview
        • 10.4.1.2 Product Description
        • 10.4.1.3 Product Status
      • 10.4.2 Future insulin infusion systems
        • 10.4.2.1 Product Overview
        • 10.4.2.2 Product Description
        • 10.4.2.3 Product Status
      • 10.4.3 Next generation durable pen
        • 10.4.3.1 Product Overview
        • 10.4.3.2 Product Description
        • 10.4.3.3 Product Status
      • 10.4.4 Next generation needles
        • 10.4.4.1 Product Overview
        • 10.4.4.2 Product Description
        • 10.4.4.3 Product Status
  • 11 Becton, Dickinson Company Profile
    • 11.1 Company Overview
    • 11.2 Business Overview
      • 11.2.1 Biosciences
      • 11.2.2 Diagnostics
      • 11.2.3 Medical
      • 11.2.4 Major Products and Services
      • 11.2.5 History
    • 11.3 Value Chain Analysis
      • 11.3.1 Manufacturing
      • 11.3.2 Product Development
      • 11.3.3 Sales and Marketing
    • 11.4 SWOT Analysis
      • 11.4.1 Becton, Dickinson and Company Strengths
      • 11.4.2 Becton, Dickinson and Company Weaknesses
      • 11.4.3 Becton, Dickinson and Company Opportunities
      • 11.4.4 Becton, Dickinson and Company Threats
    • 11.5 Financial and Operational Review
      • 11.5.1 Financial Statements
      • 11.5.2 Financial Ratios
      • 11.5.3 Share Holding Structure
    • 11.6 Locations And Subsidiaries
  • 12 Regulation System
    • 12.1 Medical Equipment Approval Process
      • 12.1.1 Classification
      • 12.1.2 Conformity Assessment
        • 12.1.2.1 Class II
        • 12.1.2.2 Class III
        • 12.1.2.3 Class IV
      • 12.1.3 License Fee
      • 12.1.4 License Application Processing Duration
    • 12.2 Labeling and Packaging
    • 12.3 Post-Market Surveillance
  • 13 Pricing and Reimbursement
  • 14 Distribution Structure
    • 14.1 Distribution Structure
  • 15 Financial Deals Landscape
    • 15.1 IPO
      • 15.1.1 Biosign Technologies Announces Private Placement Of $1.89 Million
  • 16 Appendix
    • 16.1 Global markets Direct Research Methodology
    • 16.2 Coverage
    • 16.3 Secondary Research
    • 16.4 Primary Research
    • 16.5 Models
    • 16.6 Forecasts
    • 16.7 Expert Panels
    • 16.8 Currency Conversion
    • 16.9 Contact Us
    • 16.10 Disclaimer
  • 1 List of Tables
    • Table 1: Number of Physicians by Province in Canada, 2001 and 2005
    • Table 2: Hospital Wards by Specialty in Canada, 2003-2007
    • Table 3: Doctors by Specialty in Canada, 2003-2007
    • Table 4: Diabetes Care Devices, Canada, Overall Revenues ($ mn), 2000-2012
    • Table 5: Diabetes Care Devices, Canada, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 6: Diabetes Care Devices, Canada, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 7: Diabetes Care Devices, Canada, Overall Revenues ($ mn), 2000-2012
    • Table 8: Diabetes Care Devices, Canada, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 9: Diabetes Care Devices, Canada, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 10: Diabetes Care Devices, Canada, Overall Volume (Units), 2000-2012
    • Table 11: Diabetes Care Devices, Canada, Overall Volume (Units), Historic, 2000-2007
    • Table 12: Diabetes Care Devices, Canada, Overall Volume (Units), Forecast, 2007-2012
    • Table 13: Diabetes Care Devices, Canada, Overall Company Share by Revenue ($ mn), 2006-2007
    • Table 14: Glucose Monitoring, Canada, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 15: Glucose Monitoring, Canada, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 16: Glucose Monitoring, Canada, Revenue by Segment ($ mn), Historic, 2000-2007
    • Table 17: Glucose Monitoring, Canada, Revenue by Segment ($ mn), Forecast, 2007-2012
    • Table 18: Blood Glucose Test Strips, Canada, Revenues ($ mn), Historic, 2000-2007
    • Table 19: Blood Glucose Test Strips, Canada, Revenues ($ mn), Forecast, 2007-2012
    • Table 20: Blood Glucose Meters, Canada, Revenues ($ mn), Historic, 2000-2007
    • Table 21: Blood Glucose Meters, Canada, Revenues ($ mn), Forecast, 2007-2012
    • Table 22: Glucose Monitoring, Canada, Overall Volume (Units), Historic, 2000-2007
    • Table 23: Glucose Monitoring, Canada, Overall Volume (Units), Forecast, 2007-2012
    • Table 24: Blood Glucose Test Strips, Canada, Volume (Units), Historic, 2000-2007
    • Table 25: Blood Glucose Test Strips, Canada, Volume (Units), Forecast, 2007-2012
    • Table 26: Blood Glucose Meters, Canada, Volume (Units), Historic, 2000-2007
    • Table 27: Blood Glucose Meters, Canada, Volume (Units), Forecast, 2007-2012
    • Table 28: Blood Glucose Meters, Canada, Average Price ($), Historic, 2000-2007
    • Table 29: Blood Glucose Meters, Canada, Average Price ($), Forecast, 2007-2012
    • Table 30: Blood Glucose Test Strips, Canada, Average Price ($), Historic, 2000-2007
    • Table 31: Blood Glucose Test Strips, Canada, Average Price ($), Forecast, 2007-2012
    • Table 32: Glucose Monitoring, Canada, Distribution Share by Revenue ($ mn), 2006-2007
    • Table 33: Glucose Monitoring, Canada, Company Share by Revenue ($ mn), 2006-2007
    • Table 34: Insulin Delivery, Canada, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 35: Insulin Delivery, Canada, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 36: Insulin Delivery, Canada, Revenue by Segment ($ mn), Historic, 2000-2007
    • Table 37: Insulin Delivery, Canada, Revenue by Segment ($ mn), Forecast, 2007-2012
    • Table 38: Insulin Syringes, Canada, Revenues ($ mn), Historic, 2000-2007
    • Table 39: Insulin Syringes, Canada, Revenues ($ mn), Forecast, 2007-2012
    • Table 40: Insulin Pumps, Canada, Revenues ($ mn), Historic, 2000-2007
    • Table 41: Insulin Pumps, Canada, Revenues ($ mn), Forecast, 2007-2012
    • Table 42: Insulin Pens, Canada, Revenues ($ mn), Historic, 2000-2007
    • Table 43: Insulin Pens, Canada, Revenues ($ mn), Forecast, 2007-2012
    • Table 44: Insulin Jet Injectors, Canada, Revenues ($ mn), Historic, 2000-2007
    • Table 45: Insulin Jet Injectors, Canada, Revenues ($ mn), Forecast, 2007-2012
    • Table 46: Insulin Delivery, Canada, Overall Volume (Units), Historic, 2000-2007
    • Table 47: Insulin Delivery, Canada, Overall Volume (Units), Forecast, 2007-2012
    • Table 48: Insulin Syringes, Canada, Volume (Units), Historic, 2000-2007
    • Table 49: Insulin Syringes, Canada, Volume (Units), Forecast, 2007-2012
    • Table 50: Insulin Pens, Canada, Volume (Units), Historic, 2000-2007
    • Table 51: Insulin Pens, Canada, Volume (Units), Forecast, 2007-2012
    • Table 52: Insulin Pumps, Canada, Volume (Units), Historic, 2000-2007
    • Table 53: Insulin Pumps, Canada, Volume (Units), Forecast, 2007-2012
    • Table 54: Insulin Jet Injectors, Canada, Volume (Units), Historic, 2000-2007
    • Table 55: Insulin Jet Injectors, Canada, Volume (Units), Forecast, 2007-2012
    • Table 56: Insulin Jet Injectors, Canada, Average Price ($), Historic, 2000-2007
    • Table 57: Insulin Jet Injectors, Canada, Average Price ($), Forecast, 2007-2012
    • Table 58: Insulin Pens, Canada, Average Price ($), Historic, 2000-2007
    • Table 59: Insulin Pens, Canada, Average Price ($), Forecast, 2007-2012
    • Table 60: Insulin Pumps, Canada, Average Price ($), Historic, 2000-2007
    • Table 61: Insulin Pumps, Canada, Average Price ($), Forecast, 2007-2012
    • Table 62: Insulin Syringes, Canada, Average Price ($), Historic, 2000-2007
    • Table 63: Insulin Syringes, Canada, Average Price ($), Forecast, 2007-2012
    • Table 64: Insulin Delivery, Canada, Distribution Share by Revenue ($ mn), 2006-2007
    • Table 65: Insulin Delivery, Canada, Company Share by Revenue ($ mn), 2006-2007
    • Table 66: F. Hoffmann-La Roche Ltd., SWOT Analysis, 2006
    • Table 67: F. Hoffmann-La Roche Ltd., Financial Statements, CHF Million, 2002-2006
    • Table 68: F. Hoffmann-La Roche Ltd., Financial Ratios, CHF Million, 2002-2006
    • Table 69: F. Hoffmann-La Roche Ltd., Other Locations
    • Table 70: F. Hoffmann-La Roche Ltd., Other Locations(Contd..)
    • Table 71: F. Hoffmann-La Roche Ltd., Subsidiaries
    • Table 72: LifeScan, Inc., Other Locations
    • Table 73: Abbott Laboratories, SWOT Analysis, 2006
    • Table 74: Abbott Laboratories, Financial Statements, USD Thousand, 2002-2006
    • Table 75: Abbott Laboratories, Financial Ratios, USD Thousand, 2002-2006
    • Table 76: Abbott Laboratories, Other Locations
    • Table 77: Abbott Laboratories, Subsidiaries
    • Table 78: Novo Nordisk A/S, Other Locations
    • Table 79: Novo Nordisk A/S, Subsidiaries
    • Table 80: Becton, Dickinson and Company, SWOT Analysis, 2006
    • Table 81: Becton, Dickinson and Company, Financial Statements, USD Thousand, 2002-2006
    • Table 82: Becton, Dickinson and Company, Financial Ratios, USD Thousand, 2002-2006
    • Table 83: Becton, Dickinson and Company, Share Holding Structure
    • Table 84: Becton, Dickinson and Company, Other Locations
    • Table 85: Medical Equipment Classification in Canada, 2007
    • Table 86: Medical Equipment Licensing Fee in Canada, 2007
    • Table 87: Medical Equipment License Processing Duration in Canada, 2007
    • Table 88: Currency Conversion from USD to Local Currency at 2007 Constant Rate
    • 1.2 List of Figures
    • Figure 1: Healthcare Financing in Canada, 2004
    • Figure 2: Healthcare Expenditure in Canada, 2000 - 2006
    • Figure 3: Diabetes Care Devices, Canada, Overall Revenues ($ mn), 2000-2012
    • Figure 4: Diabetes Care Devices, Canada, Overall Revenues ($ mn), Historic, 2000-2007
    • Figure 5: Diabetes Care Devices, Canada, Overall Revenues ($ mn), Forecast, 2007-2012
    • Figure 6: Diabetes Care Devices, Canada, Overall Revenues ($ mn), 2000-2012
    • Figure 7: Diabetes Care Devices, Canada, Overall Revenues ($ mn), Historic, 2000-2007
    • Figure 8: Diabetes Care Devices, Canada, Overall Revenues ($ mn), Forecast, 2007-2012
    • Figure 9: Diabetes Care Devices, Canada, Overall Volume (Units), 2000-2012
    • Figure 10: Diabetes Care Devices, Canada, Overall Volume (Units), Historic, 2000-2007
    • Figure 11: Diabetes Care Devices, Canada, Overall Volume (Units), Forecast, 2007-2012
    • Figure 12: Diabetes Care Devices, Canada, Overall Company Share (%), 2007
    • Figure 13: Glucose Monitoring, Canada, Overall Revenues ($ mn), Historic, 2000-2007
    • Figure 14: Glucose Monitoring, Canada, Overall Revenues ($ mn), Forecast, 2007-2012
    • Figure 15: Glucose Monitoring, Canada, Revenue by Segment ($ mn), Historic, 2000-2007
    • Figure 16: Glucose Monitoring, Canada, Revenue by Segment ($ mn), Forecast, 2007-2012
    • Figure 17: Blood Glucose Test Strips, Canada, Revenues ($ mn), Historic, 2000-2007
    • Figure 18: Blood Glucose Test Strips, Canada, Revenues ($ mn), Forecast, 2007-2012
    • Figure 19: Blood Glucose Meters, Canada, Revenues ($ mn), Historic, 2000-2007
    • Figure 20: Blood Glucose Meters, Canada, Revenues ($ mn), Forecast, 2007-2012
    • Figure 21: Glucose Monitoring, Canada, Overall Volume (Units), Historic, 2000-2007
    • Figure 22: Glucose Monitoring, Canada, Overall Volume (Units), Forecast, 2007-2012
    • Figure 23: Blood Glucose Test Strips, Canada, Volume (Units), Historic, 2000-2007
    • Figure 24: Blood Glucose Test Strips, Canada, Volume (Units), Forecast, 2007-2012
    • Figure 25: Blood Glucose Meters, Canada, Volume (Units), Historic, 2000-2007
    • Figure 26: Blood Glucose Meters, Canada, Volume (Units), Forecast, 2007-2012
    • Figure 27: Blood Glucose Meters, Canada, Average Price ($), Historic, 2000-2007
    • Figure 28: Blood Glucose Meters, Canada, Average Price ($), Forecast, 2007-2012
    • Figure 29: Blood Glucose Test Strips, Canada, Average Price ($), Historic, 2000-2007
    • Figure 30: Blood Glucose Test Strips, Canada, Average Price ($), Forecast, 2007-2012
    • Figure 31: Glucose Monitoring, Canada, Distribution Share (%), 2007
    • Figure 32: Glucose Monitoring, Canada, Company Share (%), 2007
    • Figure 33: Insulin Delivery, Canada, Overall Revenues ($ mn), Historic, 2000-2007
    • Figure 34: Insulin Delivery, Canada, Overall Revenues ($ mn), Forecast, 2007-2012
    • Figure 35: Insulin Delivery, Canada, Revenue by Segment ($ mn), Historic, 2000-2007
    • Figure 36: Insulin Delivery, Canada, Revenue by Segment ($ mn), Forecast, 2007-2012
    • Figure 37: Insulin Syringes, Canada, Revenues ($ mn), Historic, 2000-2007
    • Figure 38: Insulin Syringes, Canada, Revenues ($ mn), Forecast, 2007-2012
    • Figure 39: Insulin Pumps, Canada, Revenues ($ mn), Historic, 2000-2007
    • Figure 40: Insulin Pumps, Canada, Revenues ($ mn), Forecast, 2007-2012
    • Figure 41: Insulin Pens, Canada, Revenues ($ mn), Historic, 2000-2007
    • Figure 42: Insulin Pens, Canada, Revenues ($ mn), Forecast, 2007-2012
    • Figure 43: Insulin Jet Injectors, Canada, Revenues ($ mn), Historic, 2000-2007
    • Figure 44: Insulin Jet Injectors, Canada, Revenues ($ mn), Forecast, 2007-2012
    • Figure 45: Insulin Syringes, Canada, Volume (Units), Historic, 2000-2007
    • Figure 46: Insulin Syringes, Canada, Volume (Units), Forecast, 2007-2012
    • Figure 47: Insulin Pens, Canada, Volume (Units), Historic, 2000-2007
    • Figure 48: Insulin Pens, Canada, Volume (Units), Forecast, 2007-2012
    • Figure 49: Insulin Pumps, Canada, Volume (Units), Historic, 2000-2007
    • Figure 50: Insulin Pumps, Canada, Volume (Units), Forecast, 2007-2012
    • Figure 51: Insulin Jet Injectors, Canada, Volume (Units), Historic, 2000-2007
    • Figure 52: Insulin Jet Injectors, Canada, Volume (Units), Forecast, 2007-2012
    • Figure 53: Insulin Jet Injectors, Canada, Average Price ($), Historic, 2000-2007
    • Figure 54: Insulin Jet Injectors, Canada, Average Price ($), Forecast, 2007-2012
    • Figure 55: Insulin Pens, Canada, Average Price ($), Historic, 2000-2007
    • Figure 56: Insulin Pens, Canada, Average Price ($), Forecast, 2007-2012
    • Figure 57: Insulin Pumps, Canada, Average Price ($), Historic, 2000-2007
    • Figure 58: Insulin Pumps, Canada, Average Price ($), Forecast, 2007-2012
    • Figure 59: Insulin Syringes, Canada, Average Price ($), Historic, 2000-2007
    • Figure 60: Insulin Syringes, Canada, Average Price ($), Forecast, 2007-2012
    • Figure 61: Insulin Delivery, Canada, Distribution Share (%), 2007
    • Figure 62: Insulin Delivery, Canada, Company Share (%), 2007
    • Figure 63: F. Hoffmann-La Roche Ltd., Value Chain Analysis
    • Figure 64: Abbott Laboratories, Value Chain Analysis
    • Figure 65: Becton, Dickinson and Company, Value Chain Analysis
    • Figure 66: Global markets Direct Methodology